8-K
filed November 9, 2023, 6:59 PM ET
CIK 0000708818
M&A
confidence high
sentiment neutral
materiality 1.00
NEXTGEN HEALTHCARE, INC.: M&A transaction — NextGen acquired by Next Holdco for $23.95/share; stock to be delisted
NEXTGEN HEALTHCARE, INC.
- Merger completed Nov 9, 2023; NextGen shareholders receive $23.95 per share in cash.
- NextGen common stock to be delisted from Nasdaq; Form 25 filed.
- Existing credit agreement repaid and terminated; no early termination penalties.
- Convertible note indenture amended; future conversions settled entirely in cash at $23.95.
- Board of directors resigned; Peter Hernandez and A.J. Rohde appointed; David Sides remains CEO.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
A.J. Rohde was appointed as Director at NEXTGEN HEALTHCARE, INC..
- Action
- became
- Role
- Director
Exact text from the filing
Peter Hernandez and A.J. Rohde became directors of NextGen.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Peter Hernandez was appointed as Director at NEXTGEN HEALTHCARE, INC..
- Action
- became
- Role
- Director
Exact text from the filing
Peter Hernandez and A.J. Rohde became directors of NextGen.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
NEXTGEN HEALTHCARE, INC.: Certificate of incorporation amended and restated in its entirety.
- Change
- charter amendment
Exact text from the filing
the certificate of incorporation of NextGen, as in effect immediately prior to the Effective Time, was amended and restated in its entirety (the "Amended and Restated Certificate of Incorporation").
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
NEXTGEN HEALTHCARE, INC.: Bylaws amended and restated in their entirety.
- Change
- bylaw amendment
Exact text from the filing
the bylaws of NextGen, as in effect immediately prior to the Effective Time, were amended and restated in their entirety (the "Bylaws").
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
NEXTGEN HEALTHCARE, INC. underwent a change of control involving Parent.
- Action
- change of control
- Counterparty
- Parent
Exact text from the filing
As a result of the consummation of the Merger, a change of control of NextGen occurred on the Closing Date and NextGen became a wholly owned subsidiary of Parent.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
NEXTGEN HEALTHCARE, INC. terminated Second Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. valued at All outstanding indebtedness repaid in full; commitments terminated. No early termination penalties..
- Action
- termination
- Agreement
- credit facility
- Counterparty
- JPMorgan Chase Bank, N.A.
- Value
- All outstanding indebtedness repaid in full; commitments terminated. No early termination penalties.
Exact text from the filing
On the Closing Date, NextGen repaid in full all outstanding indebtedness and certain other obligations and terminated the commitments under its Second Amended and Restated Credit Agreement, dated as of March 12, 2021, among NextGen, JPMorgan Chase Bank, N.A., as administrative agent and certain other lenders party thereto, as amended (the “Existing Credit Agreement”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
NEXTGEN HEALTHCARE, INC. entered into First Supplemental Indenture with U.S. Bank Trust Company, National Association valued at Settlement entirely in cash; per $1,000 principal amount: conversion rate × $23.95.
- Action
- entry
- Agreement
- notes offering
- Counterparty
- U.S. Bank Trust Company, National Association
- Value
- Settlement entirely in cash; per $1,000 principal amount: conversion rate × $23.95
Exact text from the filing
On the Closing Date (as defined below), NextGen Healthcare, Inc., a Delaware corporation (“NextGen” or the “Company”) and U.S. Bank Trust Company, National Association (the “Trustee”), entered into the First Supplemental Indenture (the “Supplemental Indenture”) to the Indenture, dated as of November 1, 2022 (the “Base Indenture”), between NextGen and the Trustee, relating to NextGen’s 3.75% Convertible Senior Notes due 2027 (the “Notes”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.